Cercar
01/01/2022
Long-Term Results of Deep Brain Stimulation for Treatment-Resistant Depression: Outcome Analysis and Correlation With Lead Position and Electrical Parameters
Aibar-Durán J.Á., Rodríguez Rodríguez R., de Diego Adeliño F.J., Portella M.J., Álvarez-Holzapfel M.J., Martín Blanco A., Puigdemont Campos D., Molet Teixidó J.. Long-Term Results of Deep Brain Stimulation for Treatment-Resistant Depression: Outcome Analysis and Correlation With Lead Position and Electrical Parameters. Neurosurgery. 2022; 90(1)DOI:10.1227/NEU.0000000000001739. PMID:34982873. IF:4.800(Q1/1D).
01/10/2021
Structural brain abnormalities in borderline personality disorder correlate with clinical severity and predict psychotherapy response
Sampedro, F, Farres, CCI, Soler, J, Elices, M, Schmidt, C, Corripio, I, Dominguez-Clave, E, Pomarol-Clotet, E, Salvador, R, Pascual, JC. Structural brain abnormalities in borderline personality disorder correlate with clinical severity and predict psychotherapy response. Brain Imaging and Behavior. 2021; 15(5)DOI:10.1007/s11682-021-00451-6. PMID:33634348. IF:3.224(Q2/5D).
01/09/2021
Primary Nocardia brain abscesses and role of intraventricular antibiotic therapy
Pereira, MR, Cortes, CA. Primary Nocardia brain abscesses and role of intraventricular antibiotic therapy. CLINICAL NEUROLOGY AND NEUROSURGERY. 2021; 208DOI:10.1016/j.clineuro.2021.106846. PMID:34358801. IF:1.885(Q3/7D).
01/09/2021
Predicting Non-Suicidal Self-Injury in Young Adults with and without Borderline Personality Disorder: a Multilevel Approach Combining Ecological Momentary Assessment and Self-Report Measures
Briones-Buixassa, L, Ali, I, Schmidt, C, Nicolaou, S, Pascual, JC, Soler, J, Vega, D. Predicting Non-Suicidal Self-Injury in Young Adults with and without Borderline Personality Disorder: a Multilevel Approach Combining Ecological Momentary Assessment and Self-Report Measures. PSYCHIATRIC QUARTERLY. 2021; 92(3)DOI:10.1007/s11126-020-09875-7. PMID:33475912. IF:3.504(Q2/5D).
01/07/2021
Intracavernous Branches of the Internal Carotid Artery Through an Endoscopic Endonasal Approach: Anatomical Study and Review of the Literature
Aibar-Duran, JA, Munoz-Hernandez, F, Asencio-Cortes, C, Montserrat-Gili, J, Gras-Cabrerizo, JR, Mirapeix, RM. Intracavernous Branches of the Internal Carotid Artery Through an Endoscopic Endonasal Approach: Anatomical Study and Review of the Literature. World Neurosurgery. 2021; 151DOI:10.1016/j.wneu.2021.04.046. PMID:33887498. IF:2.210(Q3/6D).
01/01/2022
Guidelines for Genetic Testing and Management of Alport Syndrome
Savige, J, Lipska-Zietkiewicz, BS, Watson, E, Hertz, JM, Deltas, C, Mari, F, Hilbert, P, Plevova, P, Byers, P, Cerkauskaite, A, Gregory, M, Cerkauskiene, R, Ljubanovic, DG, Becherucci, F, Errichiello, C, Massella, L, Aiello, V, Lennon, R, Hopkinson, L, Koziell, A, Lungu, A, Rothe, HM, Hoefele, J, Zacchia, M, Martic, TN, Gupta, A, van Eerde, A, Gear, S, Landini, S, Palazzo, V, al-Rabadi, L, Claes, K, Corveleyn, A, Van Hoof, E, van Geel, M, Williams, M, Ashton, E, Belge, H, Ars, E, Bierzynska, A, Gangemi, C, Renieri, A, Storey, H, Flinter, F. Guidelines for Genetic Testing and Management of Alport Syndrome. Clinical Journal of the American Society of Nephrology. 2022; 17(1)DOI:10.2215/CJN.04230321. PMID:34930753. IF:9.800(Q1/1D).
01/12/2021
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution
Montero, N, Toapanta, N, Pallares, N, Crespo, M, Diekmann, F, Guirado, L, Esteban, R, Codina, S, Melilli, E, Buxeda, A, Velis, G, Torres, IB, Revuelta, I, Andujar, AM, Facundo, C, Bardaji, B, Riera, L, Fiol, M, Cruzado, JM, Comas, J, Giral, M, Naesens, M, Asberg, A, Moreso, F, Bestard, O. Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution. TRANSPLANT INTERNATIONAL. 2021; 34(12)DOI:10.1111/tri.14131. PMID:34626501. IF:3.842(Q1/3D).
01/11/2021
Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease
Torra, R, Perez-Gomez, MV, Furlano, M. Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease. Clinical Kidney Journal. 2021; 14(11)DOI:10.1093/ckj/sfab132. PMID:34754424. IF:5.860(Q1/2D).
01/10/2021
COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?
Coll, E, Fernandez-Ruiz, M, Padilla, M, Moreso, F, Hernandez-Vicente, A, Yanez, I, Molina, M, Vazquez-Sanchez, T, Crespo, M, Facundo, C, Rodriguez-Ferrero, ML, Fuentes, MCR, Loinaz, C, Bernal, G, Melilli, E, Bravo, C, Diekmann, F, Llado, L, Garcia-Alvarez, TM, Salcedo, M, Beneyto, I, Castells, L, Alonso, R, Rodriguez-Benot, A, Diaz-Corte, C, Graus, J, Ortiz-Bautista, C, Garcia-Cosio, MD, Hinojal, R, Pena, L, Dominguez-Gil, B. COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?. TRANSPLANTATION. 2021; 105(10)DOI:10.1097/TP.0000000000003873. PMID:34241988. IF:5.385(Q1/2D).
01/10/2021
Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study
Sommerer, C, Brunet, M, Budde, K, Millan, O, Perich, LG, Glander, P, Meuer, S, Zeier, M, Giese, T. Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2021; 87(10)DOI:10.1111/bcp.14794. PMID:33620734. IF:3.716(Q2/5D).
01/10/2021
Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
Bover, J, Gunnarsson, J, Csomor, P, Kaiser, E, Cianciolo, G, Lauppe, R. Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis. Clinical Kidney Journal. 2021; 14(10)DOI:10.1093/ckj/sfab035. PMID:34603696. IF:5.860(Q1/2D).
01/09/2021
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease
Bichet, DG, Torra, R, Wallace, E, Hughes, D, Giugliani, R, Skuban, N, Krusinska, E, Feldt-Rasmussen, U, Schiffmann, R, Nicholls, K. Long-term follow-up of renal function in patients treated with migalastat for Fabry disease. Molecular Genetics and Metabolism Reports. 2021; 28DOI:10.1016/j.ymgmr.2021.100786. PMID:34401344. IF:2.082(Q4/9D).
01/09/2021
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
Buxeda, A, Arias-Cabrales, C, Perez-Saez, MJ, Cacho, J, Pelegrin, SC, Melilli, E, Aladren, MJ, Galeano, C, Lorenzo, I, Mazuecos, A, Saura, IM, Franco, A, Ruiz-Fuentes, MD, Sanchez-Camara, LA, Siverio, O, Martin, ML, Gonzalez-Garcia, E, Lopez, V, Martin-Moreno, PL, Moina, I, Berrio, EM, Moreso, F, Portoles, JM, Santana-Estupinan, R, Zarraga, S, Canal, C, Sanchez-Alvarez, E, Pascual, J, Crespo, M. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19. Kidney International Reports. 2021; 6(9)DOI:10.1016/j.ekir.2021.06.023. PMID:34250317. IF:6.234(Q1/2D).
01/09/2021
A urinary stone from the early medieval site of Riner, Catalonia
Oller, NA, Gracia-Gracia, S, Cugat, JB, Vicente, IG, Exposito, IM, Casafont, JL. A urinary stone from the early medieval site of Riner, Catalonia. International Journal of Paleopathology. 2021; 34DOI:10.1016/j.ijpp.2021.07.006. PMID:34315047. IF:1.448(Q3/8D).
01/08/2021
Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation
Millan, O, Rovira, J, Guirado, L, Espinosa, C, Budde, K, Sommerer, C, Pineiro, GJ, Diekmann, F, Brunet, M. Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation. CLINICAL IMMUNOLOGY. 2021; 229DOI:10.1016/j.clim.2021.108792. PMID:34217849. IF:10.190(Q1/2D).
01/08/2021
Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
Savige, J, Storey, H, Watson, E, Hertz, JM, Deltas, C, Renieri, A, Mari, F, Hilbert, P, Plevova, P, Byers, P, Cerkauskaite, A, Gregory, M, Cerkauskiene, R, Ljubanovic, DG, Becherucci, F, Errichiello, C, Massella, L, Aiello, V, Lennon, R, Hopkinson, L, Koziell, A, Lungu, A, Rothe, HM, Hoefele, J, Zacchia, M, Martic, TN, Gupta, A, van Eerde, A, Gear, S, Landini, S, Palazzo, V, Al-Rabadi, L, Claes, K, Corveleyn, A, Van Hoof, E, van Geel, M, Williams, M, Ashton, E, Belge, H, Ars, E, Bierzynska, A, Gangemi, C, Lipska-Zietkiewicz, BS. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. EUROPEAN JOURNAL OF HUMAN GENETICS. 2021; 29(8)DOI:10.1038/s41431-021-00858-1. PMID:33854215. IF:5.351(Q1/2D).
01/08/2021
Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients
Ammar, S, Kanoun, H, Kammoun, K, Domingo-Gallego, A, Ruiz, P, Lorente-Grandoso, L, Pybus, M, Maalej, B, Boudawara, T, Kamoun, H, Ben Hmida, M, Ars, E, Jarraya, F. Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients. JOURNAL OF HUMAN GENETICS. 2021; 66(8)DOI:10.1038/s10038-021-00912-2. PMID:33654185. IF:3.767(Q2/5D).
01/08/2021
Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports
Torra, R, Furlano, M, Ortiz, A, Ars, E. Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clinical Kidney Journal. 2021; 14(8)DOI:10.1093/ckj/sfab056. PMID:34345410. IF:5.860(Q1/2D).
01/07/2021
Improved office blood pressure control by automatic delayed-reading oscillometric device
Coll-Brito, V, Calero, F, Arias, P, Ayasreh, N, Ochoa, J, Ramos, A, Guirado, L, Fernandez-Llama, P. Improved office blood pressure control by automatic delayed-reading oscillometric device. Hipertension Y Riesgo Vascular. 2021; 38(3)DOI:10.1016/j.hipert.2021.03.002. PMID:33893057. IF:(Q/D).
01/07/2021
Bisphenol a Exposure and Kidney Diseases: Systematic Review, Meta-Analysis, and NHANES 03-16 Study
Moreno-Gomez-Toledano, R, Arenas, MI, Velez-Velez, E, Coll, E, Quiroga, B, Bover, J, Bosch, RJ. Bisphenol a Exposure and Kidney Diseases: Systematic Review, Meta-Analysis, and NHANES 03-16 Study. Biomolecules. 2021; 11(7)DOI:10.3390/biom11071046. PMID:34356670. IF:6.064(Q2/3D).